Enokizumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Enokizumab
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target IL9
Clinical data
ATC code
  • none
Identifiers
ChemSpider
  • none
UNII
Chemical and physical data
Formula C6492H10000N1704O2038S44
Molar mass 148.4 kg/mol
 NYesY (what is this?)  (verify)

Enokizumab is a humanized monoclonal antibody designed for the treatment of asthma.[1]

Enokizumab was developed by MedImmune.

References[edit]

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Enokizumab" (PDF). American Medical Association.